Iovance Biotherapeutics, Inc.IOVANASDAQ
Loading
Year-over-year net income growth rate
Latest
21.20%
↑ 397% vs avg
Percentile
P100
Near historical high
Streak
3 qtr
Consecutive growthAccelerating
Average
-7.14%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 21.20% |
| Q3 2025 | 18.27% |
| Q2 2025 | 3.88% |
| Q1 2025 | -47.87% |
| Q4 2024 | 5.96% |
| Q3 2024 | 13.96% |
| Q2 2024 | 14.05% |
| Q1 2024 | 2.92% |
| Q4 2023 | -2.30% |
| Q3 2023 | -6.79% |
| Q2 2023 | 0.78% |
| Q1 2023 | -1.95% |
| Q4 2022 | -5.72% |
| Q3 2022 | -0.27% |
| Q2 2022 | -8.45% |
| Q1 2022 | 7.78% |
| Q4 2021 | -15.34% |
| Q3 2021 | -5.86% |
| Q2 2021 | -7.82% |
| Q1 2021 | -10.31% |
| Q4 2020 | -16.78% |
| Q3 2020 | 7.06% |
| Q2 2020 | 9.45% |
| Q1 2020 | -9.48% |
| Q4 2019 | -28.45% |
| Q3 2019 | -4.07% |
| Q2 2019 | -28.69% |
| Q1 2019 | -13.43% |
| Q4 2018 | 3.71% |
| Q3 2018 | -10.34% |
| Q2 2018 | -15.63% |
| Q1 2018 | -2.56% |
| Q4 2017 | -16.73% |
| Q3 2017 | 5.25% |
| Q2 2017 | -13.02% |
| Q1 2017 | -31.84% |
| Q4 2016 | 16.36% |
| Q3 2016 | -62.22% |
| Q2 2016 | -67.97% |
| Q1 2016 | 17.82% |